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Membrane proteinCytochrome (cyt) b561 proteins are dihaem-containing membrane proteins, belonging to the CYBASC (cyto-
chrome-b561-ascorbate-reducible) family, and are proposed to be involved in ascorbate recycling and/or the fa-
cilitation of iron absorption. Here, we present the heterologous production of two cyt b561 paralogs from
Arabidopsis thaliana (Acytb561-A, Acytb561-B) in Escherichia coli and Pichia pastoris, their puriﬁcation, and initial
characterisation. Spectra indicated that Acytb561-A resembles the best characterisedmember of the CYBASC fam-
ily, the cytochrome b561 from adrenomedullary chromafﬁn vesicles, and that Acytb561-B is atypical compared to
other CYBASC proteins. Haemoxidation–reductionmidpoint potential (EM) valueswere found to be fully consis-
tent with ascorbate oxidation activities and Fe3+-chelates reductase activities. The ascorbate dependent reduc-
tion and protein stability of both paralogs were found to be sensitive to alkaline pH values as reported for the
cytochrome b561 from chromafﬁn vesicles. For both paralogs, ascorbate-dependent reduction was inhibited
and the low-potential haem EM values were affected signiﬁcantly by incubation with diethyl pyrocarbonate
(DEPC) in the absence of ascorbate. Modiﬁcationwith DEPC in the presence of ascorbate left the haem EM values
unaltered compared to the unmodiﬁed proteins. However, ascorbate reductionwas inhibited.We concluded that
the ascorbate-binding site is located near the low-potential haemwith the Fe3+-chelates reduction-site close to
the high-potential haem. Furthermore, inhibition of ascorbate oxidation by DEPC treatment occurs not only by
lowering the haem EM values but also by an additional modiﬁcation affecting ascorbate binding and/or electron
transfer. Analytical gel ﬁltration experiments suggest that both cyt b561 paralogs exist as homodimers.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Cytochrome (cyt) b561 proteins are di-haem containing membrane
proteins that can shuttle one electron across the lipid bilayer and belong
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membrane-spanning α-helices, four conserved His residues likely to
be involved in the coordination of two haem b centres, and the putative
ascorbate and mono-dehydroascorbate (MDHA) binding motifs
[1,13–15] (Supplementary Fig. S1). While investigation of animal
CYBASC members has proceeded rapidly in the recent years, little has
been presented on plant CYBASC and the physiological function in
plants of this redox family is still unknown. The ﬁrst putative cyt b561
puriﬁed from the plasma membrane of bean hypocotyls (Pcytb561-I),
was long believed to be the plant counterpart of the bovine chromafﬁn
granule cyt b561 [16,17]. However, a recent extensive biochemical char-
acterisation of Pcytb561-I has shown that this cytochrome is not a
CYBASC member [18]. To date, the puriﬁed plant CYBASC proteins are
the Acytb561-A from Arabidopsis thaliana [8,19,20], Ccytb561-A from
wild water melon [21], a cyt b561 from bean (Pcytb561-II) [22] and one
protein from Zeamays (Zmcytb561) [23]. Although all these proteins dis-
played typical CYBASC features, they have been found in different sub-
cellular compartments and may perform different physiological
functions. For instance, Acytb561-A and the Pcytb561-II from bean are
localised in the tonoplast and both are proposed to be involved in iron
homeostasis [8,18,19], while the Ccytb561-A has been identiﬁed in the
plasmamembrane and is proposed to be involved in energy dissipation
[21].
The A. thaliana genome appears to contain four cytb561 genes
[1,24,25]. Based on microarray data and ESTs (expressed sequence
tags), all of them are expressed in vivo (RNA level). On the protein
level, the two genes artb561-a and artb561-b were shown to be
expressed [13,19,26]. In addition, expression of cytb561 proteins was
shown in Rhaphanus sativus [26].
Currently, no experimentally determined three-dimensional
atomic model of any CYBASC member has been reported. Therefore,
studies that enable production of CYBASC members are essential
to future structural studies of representatives of this superfamily.
Here we present the heterologous production in Escherichia coli and
Pichia pastoris strains and the initial biochemical characterisation of
Acytb561-A and Acytb561-B, two distinct members of the CYBASC
family. The absorbance spectra of reduced Acytb561-B differed from
those of chromafﬁn granule cyt b561 and Acytb561-A. However, bio-
chemical characterisation of the puriﬁed Acytb561-A and Acytb561-B
conﬁrmed that both proteins are CYBASC members.2. Material and methods
2.1. Generation of expression constructs
In order to introduce the coding sequence for the streptavidin af-
ﬁnity tag II (SII) and deca-histidine (H10) afﬁnity tag into the
pPIC3.K expression vector (Invitrogen), two complementary ssDNA
oligonucleotides were synthesised (around 90 base pairs each),
annealed and ligated to the pPIC3.5K plasmid previously digested
with BamHI/NotI restriction endonucleases (BioLab). The artb561-b
ORF was ampliﬁed by PCR using the ′CGG AAT TCG CGG TTC CGG
TGC TG′ and′CGA CCC TAG GTT GTG TGA GAA CTT GAT CC′ primers.
Fragments were digested with the AvrII and EcoRI restriction endonu-
cleases (BioLab) and cloned into the AvrII and EcoRI restriction sites of
the pPIC3.5K-SII/H10 derivative. In order to insert the ORFs encoding
for the cyt b561 proteins into the pBAD expression vector derivatives,
artb561-a was ampliﬁed using the ′GTA GCT GAG ATC TTC GCT GTC
CGG ATA AAC′ and ′GTA GCT GGA ATT CGC TAT AGC AGA ATA ACT′
primers while the artb561-b was ampliﬁed with ′GTA GCT GAG ATC
TTC GCG GTT CCG GTG CTG′ and ′GTA GCT GGA ATT CCG TTG TGT
GAG AAC TTG′ primers. The DNA fragments so obtained and the
pBAD expression vector derivatives were digested with BglII and
EcoRI restriction endonucleases (BioLab) and ligated together. In all
cases, the correct insertion of the ORFs into the expression vectorderivatives was veriﬁed by colony PCR, restriction analysis and DNA
sequencing (SeqLab GmbH, Göttingen).
2.2. Protein production in P. pastoris and membrane preparation
Protein production in P. pastoris was performed essentially as de-
scribed previously for other membrane proteins by Weiss and co-
workers [27] and is described in detail in the supplementary
material. Normally from 12 L of cell culture, 100–120 g wet weight
of cell pellet were obtained. The membrane preparation steps are de-
scribed in detail in the supplementary material.
2.3. Creation of a methionine-auxotrophic E. coli strain
Methionine-auxotrophic strains of E. coli Top10-pRARE (F- mcrA
Δ(mrr-hsdRMS-mcrBC)φ80lacZΔM15ΔlacX74 recA1 araD139Δ(araleu)
7697 galU galK rpsL (StrR) endA1 nupG) (Invitrogen)were obtained after
mutagenesis with N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) and
negative selection using ampicillin [28]. The procedure is described in
detail in the supplementary material.
2.4. Protein production in E. coli and membrane preparation
Protein production in E. coli was performed essentially as de-
scribed previously for other membrane proteins by Surade and co-
workers [29] and is described in detail in the supplementary
material. Normally from 24 L cell culture, 40–60 g wet weight of cell
pellet were obtained. The membrane preparation steps are described
in detail in the supplementary material.
2.5. Protein quantiﬁcation and puriﬁcation (by IMAC)
Protein concentration was determined using the BCA Kit (Pierce)
protocol [30] using bovine serum albumin (BSA) as a standard. Puriﬁed
proteinswere concentrated by pressure dialysis using 14 mL concentra-
tors with a cut-off of 30 kDa (Amicon). Puriﬁcation was performed
using cell membranes obtained from, respectively, 2 L of P. pastoris or
24 L of E. coli cell culture. All chromatographic steps were performed
at 4 °C with ice-cold buffers and at a ﬂow rate of 0.5 ml/min on an
ÄKTA Puriﬁer system (GE Healthcare). Cell membranes at 5 mg/mL
total protein concentration were solubilised in the dark with constant
stirring at 4 °C for 2 h in 50 mM Na-phosphate pH 7.2, 350 mM NaCl,
10% glycerol (buffer A), with the addition of 1% Fos-choline 12
(Fos12), 25 mM ascorbate, 1 M betaine and 0.5 mMhistidine. Insoluble
material was separated from solubilised proteins by ultracentrifugation
at 100,000×g for 1 h at 4 °C. The supernatant was ﬁltered through a
0.2 μm ﬁlter and loaded onto a HisTrap™ column (GE Healthcare)
pre-equilibrated in 50 mM Na-phosphate pH 7.2, 350 mM NaCl, 10%
glycerol, 0.1% Fos12 (buffer A1). The column was washed with 10 col-
umn volumes (CV) of buffer A1. In order to exchange the detergent
from Fos12 to n-dodecyl-β-D-maltoside (DDM), the columnwas equil-
ibrated with 5 CV of buffer A2 (50 mM Na-phosphate pH 7.2, 350 mM
NaCl, 10% glycerol, 0.1% DDM). This was followed by a second wash in
buffer A2 mixed with 2.5% buffer B (50 mM Na-phosphate pH 7.2,
350 mM NaCl, 10% glycerol, 250 mM histidine, 15 mM ascorbate,
5 mM betaine). The recombinant cyt b561 was eluted from the column
in 100% buffer B.
2.6. Analytical gel ﬁltration
The IMAC-puriﬁed cyt b561 proteins were analysed using a
Superdex 200 PV 3.2/30 gel ﬁltration column on a Smart chromato-
graphic station (GE Healthcare). The Superdex 200 column was
equilibrated at room temperature with at least 2.5 bed volumes of
buffer A2 (50 mM Na-phosphate pH 7.2, 350 mM NaCl, 10% glycerol,
0.1% DDM). 50 μL of 1 mg/ml puriﬁed recombinant cyt b561 proteins
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and aliquots of 60 μL each were collected during the separation.
Both sample absorbance at 280 nm (A280) and at 415 nm (A415)
were monitored continuously. Aliquots corresponding to the peak
of the A280 and/or A415 were analysed by electrophoresis on SDS-
polyacrylamide gels.
2.7. Photometric haem quantiﬁcation
Absorption spectra were recorded by means of a double beam
Lambda 40 model spectrophotometer (PerkinElmer) at room temper-
ature. The amount of puriﬁed cyt b561 was estimated based on the
haem content that was calculated by subtracting the absorbance at
575 nm (A575) from the absorbance at 561 nm (A561), divided by the
molar absorption coefﬁcient of 34.2 mM−1 cm−1 [31], divided by
two in a reduced (dithionite-treated) minus oxidised (ferricyanide-
treated) spectra.
2.8. Modiﬁcation with DEPC
The recombinant puriﬁed Acytb561 proteins (2–5 μM) were oxi-
dised completely with ﬁnal concentrations of 400 μM ferricyanide,
as monitored spectrophotometrically between 400 nm and 600 nm.
To remove the ferricyanide, the samples were passed through a
PD10 desalting column (GE Healthcare) and re-equilibrated in buffer
A2 (50 mM Na-phosphate pH 7.2, 350 mM NaCl, 10% glycerol, 0.1%
DDM) and another spectrum between 400 and 600 nm was recorded.
The oxidised sample was then divided into aliquots and diluted with
equal volume of, respectively, buffer A2 (negative control), 10 mM
DEPC in buffer A2, and 10 mM DEPC with 25 mM ascorbate in buffer
A2. After incubation at room temperature for 1 h in the dark, all sam-
ples were re-equilibrated in buffer A2 using a PD10 column and con-
centrated to 1 μM. Absorption spectra were recorded before and after
addition of 5 mM ascorbate and after the addition of solid dithionite.
2.9. Reduction of ferric chelates
To stably reduce the cytochromes, the recombinant puriﬁed
Acytb561 proteins (2 μM) were incubated for 15 min at room temper-
ature in the dark with 40 mM ascorbate and 10 mM betaine in buffer
A (50 mM Na-phosphate pH 7.2, 10% glycerol, 350 mM NaCl, 0.1%
DDM). Ascorbate and betaine removal was achieved by re-
equilibration in buffer A using a PD10 column. Spectra were recorded
before and after the addition of 4 mM, 8 mM and 16 mM Fe3+-EDTA.
The procedure was analogous for Fe3+-citrate. For the kinetic activity
measurements, the paralogs were incubated with 100 mM ascorbate
over night, after which ascorbate was removed using a PD10 column.
Measurements were started by adding 2 μM of the Fe3+ chelates. The
activitieswere calculated from the time dependence of the A561−A575
absorption differences. One unit (U) is deﬁned as the amount ofTable 1
Recombinant cytochromes produced in P. pastoris and in E. coli.
Name of recombinant
protein
Expression
system strain
N-term
fusion tag
paralog C-term
fusion
EcAcytb561-AH E. coli No tag cytb561-A Tev, H
Top10 pRare met-
EcAcytb561-BHS E. coli H6, Tev cytb561-B SII
C43-
PpAcytb561-BSH P. pastoris SII cytb561-B H10
SMD1163
Abbreviations: meth-, methionine auxotrophic; N-term, amino-terminus; C-term, carboxy-t
www.expasy.ch/); Exp, experimental; SDS-PAGE, sodium dodecyl sulphate polyacrylamide
bacco etch virus (TEV) protease consensus sequence; H6, hexa-histidine afﬁnity tag; H10, dcytochrome b561 proteins which is oxidised by the Fe3+-chelates (or
which is reduced by ascorbate, see Section 2.12).
2.10. Determination of haem midpoint potentials of the recombinant
puriﬁed Acytb561 proteins
Using the electrochemical cell described earlier [32], haem
oxidation–reduction midpoint potentials of puriﬁed Acytb561-A and
Acytb561-B were determined by potentiometric titrations, in analogy
to previously published procedures for other dihaem-containing
membrane proteins [33–35] and described in detail in the supple-
mentary material.
2.11. Isoelectric focusing of the recombinant puriﬁed Acytb561 proteins
At least 0.5 mg of recombinant puriﬁed Acytb561 proteins were
analysed in a pH range of 3 to 10 by liquid phase isoelectro focusing
(IEF) using the Rotofor™Cell (BioRad) following the speciﬁcations of
the manufacturer.
2.12. Kinetic analysis of ascorbate oxidation
The sampleswere treated as described in Section 2.8.Measurements
were started by the addition of 5 μM ascorbate. Initial rates were
determined by a linear ﬁt to the time dependence of the A561−A575 ab-
sorption differences. In order to facilitate the discussion, the values
obtained for the controls were set to be 100% and the catalytic activities
determined for the different sampleswere expressed as relative catalyt-
ic activities (RCA).
3. Results
3.1. Heterologous production and puriﬁcation of the Acytb561 proteins in
yeast and bacterial cells
The artb561-a and artb561-b ORFs, coding for two putative cyt b561
paralogs, were expressed in P. pastoris and in E. coli cells (see Supple-
mentary Figs. S2 and S3). Based on the characterisation performed to
date and apart from the production yield, there were no differences
apparent between the two production systems. The recombinant
proteins obtained were named according to the name of the
paralog, with the expression system indicated in the superscript
(Pp for P. pastoris and Ec for E. coli) and the afﬁnity tag associated
with the recombinant cytochromes indicated in the subscript, e.g.
the Acytb561-B produced in P. pastoris in frame with the SII and H10
afﬁnity tags was named PpAcytb561-BSH (Table 1).
We found that the respective induction times of 20 h for P. pastoris,
of 3 h (B-paralog) and of 5 h (A-paralog) for E. coli were sufﬁcient to
obtain the maximum yield (see Material and methods). Immunoblot
analysis against the His afﬁnity tag of cell membranes obtainedtag
MW 1
(kDa)
Apparent MW
(kDa) SDS-PAGE
Apparent MW
(kDa) GF
Cal. pI1 Exp. pI
10 29.2 26 100 6.7 6.7
29.6 24 137 9.1 n.d.
29.5 22 147 9.4 9.4
erminus; MW, molecular weight; cal, calculated; 1data obtained using ExPaSy (http://
gel electrophoresis; GF, gel ﬁltration; pI, isoelectric point; TEV, coding sequence for to-
eca-histidine afﬁnity tag; SII, streptavidin afﬁnity tag II.
Fig. 1. SDS-PAGE andWestern Blot, analytical gel ﬁltration and oligomeric state analyses of the puriﬁed recombinant cyt b561 proteins from A. thaliana. (a) Fractions from the afﬁnity
column containing the puriﬁed cytochrome were pooled and purity assessed by SDS-PAGE analysis. Lane 1: puriﬁed EcAcytb561-AH (SDS-PAGE); lane 2: puriﬁed EcAcytb561-BHS
(Western Blot); lane 3: puriﬁed PpAcytb561-BSH (SDS-PAGE). (b) Molecular weight calibration using a Superdex 200 PV 3.2/30 gel ﬁltration column on a Smart Chromatographic
station (GE Healthcare). The eight proteins shown in the ﬁgure (and their molecular weights) are: ribonuclease A (a, 13.7 kDa), chymotrypsinogen (b, 25 kDa), ovalbumin
(c, 43 kDa), albumin (d, 67 kDa), aldolase (e, 158), catalase (f, 232 kDa), ferritin (g, 440 kDa), and thyroglobulin, (h, 669 kDa). Using this MW calibration, the MW of the three
protein-detergent complexes speciﬁed in panel a 1–3 were determined as listed in Table 1; Kav: partition coefﬁcient [62]. (c) Comparison of the dithionite reduced minus ferricy-
anide oxidised visible-spectra of EcAcytb561-AH (solid line, asymmetric maximum at 562 nm and a shoulder at 557 nm) and EcAcytb561-BHS (dashed line, symmetric maximum at
561 nm). (d–f) Homogeneity analysis by size-exclusion chromatography using a Superdex 200 column (Pharmacia). The symbol x in Ax stands for 280 nm (black) and 415 nm
(grey) (d) EcAcytb561-AH, retention volume (Vret)=1.4 mL (e) EcAcytb561-BHS (Vret=1.34 mL) and (f) PpAcytb561-BSH (Vret=1.33 mL). The increase of absorbance at 280 nm at
the end of the run of the analytical gel ﬁltration was due to the presence of ascorbate (maximum absorbance at 340 nm). SDS-PAGE analysis of the corresponding fractions revealed
no protein band (data not shown). In addition, when analytical gel ﬁltration of EcAcytb561-AH (d) and PpAcytb561-BSH (e) was performed in the absence of ascorbate, this peak did not
appear.
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the PpAcytb561-BSH as a single band of 22 kDa (Figs. 1a and S2). The
same analysis of membranes from transformed E. coli cells revealed
the presence of EcAcytb561-AH as a single band at 26 kDa and
of EcAcytb561-BHS at 24 kDa (Figs. 1a and S3). In both the yeast and
the bacterial expression systems, no band was detected in the immu-
noblot of the cell membranes of untransformed cells and of cells trans-
formed with empty vector (data not shown).
Immunoblot analyses indicated that the highest solubilisation
level of the recombinant cytochromes was obtained with the deter-
gent Fos12 (Table 2). The recombinant cytochromes were puriﬁed
by a single step immobilised metal afﬁnity chromatography (IMAC)(Fig. 1a). During IMAC, the Fos12 detergent was replaced by the neu-
tral detergent DDM. In order to preserve the amount of reducible
haem of the puriﬁed paralogs, we added 15 mM ascorbate and
5 mM betaine to the elution buffer. The recombinant proteins puriﬁed
following this strategy were pure (Fig. 1a), homogeneous (Fig. 1b,
d–f), and stable (Fig. S5). Comparison of the retention volume ob-
served from the analytical gel ﬁltration of the puriﬁed Acytb561 pro-
teins with the MW calibration generated (described in Fig. 1b)
indicates that both cytochromes are present in the dimeric form
when solubilised (Table 1). Similar results were also reported for the
cyt b561 from bovine chromafﬁn vesicle produced in P. pastoris [31]
and for the Pcytb561-II [18].
Table 2
Puriﬁcation of recombinant Acytb561 proteins heterologously produced in E. coli (24 L)
and P. pastoris cells (2 L).
Production
system
Paralog Total
protein
(mg)
Total
cyt b561
(mg)
Yield
(%)
Puriﬁcation
fold
E. coli EcAcytb561-AH
Fos12 extracted 750 3.6* 100 1
IMAC puriﬁed 1.6 1# 28 130
E. coli EcAcytb561-BHS
Fos12 extracted 600 4.0* 100 1
IMAC puriﬁed 1.7 1.1# 28 96
P. pastoris PpAcytb561-BSH
Fos12 extracted 1000 7.7 100 1
IMAC puriﬁed 2 1#⁎ 13 75
The speciﬁc content of cyt b561 was determined from the differences between
ascorbate-reduced* or dithionite-reduced# against the ferricyanide-oxidised absor-
bance spectra as described in experimental procedures.
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Acytb561 proteins
The spectrum of the puriﬁed A-paralog displayed the typical asym-
metric α-band (Fig. 1c), similar to the native and recombinant bovine
chromafﬁn vesicle cyt b561 [36,37], whereas that of the B-paralog
displayed a symmetric α-band with its maximum centred at 561 nm
(Fig. 1c). This difference is not attributable to the use of different ex-
pression systems, as the reduced-minus-oxidised absorbance spectra
of Acytb561-B produced either in P. pastoris or in E. coli cells were virtu-
ally identical (see Supplementary Fig. S4). In addition, this feature is
not due to the loss of any haem centre. Analysis of the cofactor content
was found to be 1.7 haem groups per cyt b561 monomer both for the
puriﬁed EcAcytb561-AH and EcAcytb561-BHS. This ratio is in the range
reported for bovine chromafﬁn vesicle cyt b561 from native and heter-
ologous sources [38]. The presence of two titratable haem centres was
also conﬁrmed by potentiometric titrations monitoring the α-band
absorbance. The values of the haem oxidation–reductionmidpoint po-
tentials of the puriﬁed Acytb561 proteins (Fig. 2a and b) were in the
same range as those of animal chromafﬁn vesicle cyt b561 [39–41]. Fur-
thermore we could conﬁrm independently the haem redox midpoint
potentials for the A-paralog which were published by Desmet et al.
in 2011 [20].Fig. 2. Overview of the values of the redox midpoint potential of the haem b groups and of th
ples were portioned and the samples were not treated (C), treated with DEPC (D) or with D
different samples (C, D, D+A) were performed with the electrochemical cell [32]. Compari
kinetic activity measurements of ascorbate oxidation, cytochrome samples were oxidised w
adding 5 μM ascorbate. (c, d) Relative catalytic activities of the A-paralog (c) and B-paralog (
(+/−3.5 U/mg; B-paralog).Consistent with the haem redox midpoint potentials of the two
paralogs, both cytochromes were promptly reduced by ascorbate. This
compound is believed to be the physiological electron donor of cyt
b561 proteins [13,18]. Therefore, the reduction by ascorbate of both pu-
riﬁed cytochromes was monitored and relative catalytic activities were
calculated (Fig. 2c and d). Even at high ascorbate concentrations
(40 mM), full reduction of both haem centres was not achievable. This
could, however, be observed when using the non-physiological reduc-
tant sodium dithionite. The ascorbate reducibility of A. thaliana paralogs
resembled that of Pcytb561-II [18]. All plant CYBASC proteins studied
(Pcytb561-II and both A. thalianaparalogs in thiswork) could be reduced
only up to 80% by ascorbate (Fig. 3e and [18]).
In addition we found that both paralogs could be oxidised by differ-
ent Fe3+ chelates (Fe3+-EDTA and Fe3+-citrate, Fig. 3a–d) [8,18,19].
Since the ferric-reductase activity of the non inhibited A-paralog was
too high for kinetic measurements in our experimental setup, we used
the DEPC modiﬁed A-paralog in its place. In contrast to the A-paralog
the activities of B-paralog could be measured without any inhibition
(Fig. 3f). Our results indicated that the reduction of Fe3+ -EDTA is
higher than that of Fe3+ -citrate. We found the speciﬁc activity for the
reduction of Fe3+ EDTA to be 1.2 U/mg (+/−0.4 U/mg) for themodiﬁed
A-paralog and 0.6-U/mg (+/−0.1 U/mg) for the B-paralog (Fig. 3f). For
the reduction of Fe3+-citrates, the speciﬁc activities were 0.05 U/mg
(+/−0.0005; A-paralog) and 0.14 U/mg (+/−0.04; B-paralog).
3.3. Effect of pH on the ascorbate-dependent reduction and stability of
the recombinant Acytb561 proteins
The experimental pI values of the puriﬁed EcAcytb561-AH
and PpAcytb561-BSH were investigated by analytical liquid-phase IEF
(BioRad) with the pH value of the electrolyte ranging 3 to 10. All frac-
tions were analysed by SDS-PAGE and the amount of the dithionite
reducible haem was calculated as previously described (see Supple-
mentary Fig. S6). The results revealed that the A-paralog was clearly
more acidic (pI=6.7) than the B-paralog (pI=9.2) (Table 1). The de-
duced pI values for other animal and plant CYBASC proteins are gen-
erally in the same range; e.g. the pI value of bovine chromafﬁn
granule cyt b561 is 6.2 [41], the calculated pI values of human duode-
nal cyt b561 is 9.12 and that of human lysosomal cyt b561 is 9.48. All
theoretical pI data were calculated using the ProtParam tool software
(http://www.expasy.ch/tools/protparam.html, [42]). The observed pI
values of the puriﬁed A. thaliana cyt b561 paralogs were surprisinglye relative catalytic activities (RCA) of the A- and B-paralog. Puriﬁed cytochromes sam-
EPC and ascorbate (D+A). Haem-potentiometric reductive-oxidative titrations of the
son of the different EM7.2 values of the A- paralog (a) and of the B-paralog (b). For the
ith ferricyanide. After ferricyanide removal, the kinetic measurements were started by
d). The values of the controls were 2.2 U/mg (+/−0.2 U/mg; A-paralog) and 12.8 U/mg
Fig. 3. Biochemical characterisation of puriﬁed EcAcytb561-AH and PpAcytb561-BSH via absorbance spectroscopy. Ferric-reductase activity of the puriﬁed cytochromes was evaluated
after reduction with 40 mM ascorbate (black lines in panels a, b, c and d). Prior to the addition of the Fe3+-chelate, samples were equilibrated in the same buffer without reductants
and a new spectrum was recorded. Oxidation of the (a) EcAcytb561-AH by Fe3+-EDTA (dashes), (b) PpAcytb561-BSH by Fe3+-EDTA (dashes), (c) EcAcytb561-AH by Fe3+-citrate
(dashes), and (d) PpAcytb561-BSH by Fe3+-citrate (dashes). (e) Reducibility at increasing concentrations of ascorbate of the puriﬁed EcAcytb561-AH (squares) and PpAcytb561-BSH
(circle). Cytochromes were oxidised with 400 μM ferricyanide and then equilibrated in the same buffer without ferricyanide. 0.1 mM, 0.5 mM, 2 mM, 5 mM, 10 mM, 20 mM and
40 mM ﬁnal concentration ascorbate were added directly to the cuvette. The percentages of the amount of ascorbate reduced haem were calculated with the respect to the amount
of dithionite reducible haem. (f) Speciﬁc activities of ferric-chelate reduction of the DEPC-modiﬁed A-paralog and the untreated B-paralog. Samples were incubated with 100 mM
ascorbate overnight, separated and the reaction was started by adding 2 μM Fe3+-chelates. The changes in the A561 and A575 absorptions were monitored over the time.
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periments, the content of ascorbate- and dithionite-reducible haem
in each fraction was determined (Fig. 4). Ascorbate reduction of
the EcAcytb561-AHwas increased at pH values lower than 6.5 (the differ-
ence between the reducibility obtained with ascorbate and dithionite is
minimal), while already at pH values greater than 7.5, the ascorbate re-
duction was decreased (Fig. 4a). This decrease was less pronounced in
the case of PpAcytb561-BSH (Fig. 4b). The sensitivity to mildly alkaline
pH values of the two Acytb561 proteins differed from the behaviour of
the bovine chromafﬁn granule cyt b561 produced in bacterial cells that
was reported to be unaffected by the change in pH [38]. In contrast,
the native chromafﬁn granule cyt b561 was reported to be sensitive to
alkaline pH [43–45]. For both puriﬁed A. thaliana cyt b561 proteins, the
total haem reducibility (dithionite reducibility, Fig. 4a–b) showed a
trend similar to that of the ascorbate reducibility. The decrease due to
alkaline pH values was even more evident for the haem reducibility
after two days of incubation at different pH values (Fig. 4c).
3.4. Inhibition by DEPC and redox titration of DEPC-modiﬁed recombinant
Acytb561 proteins
To ascertain whether the ascorbate-dependent reduction of
A- and B-paralogs was inhibited by DEPC, samples oxidised pre-
viously with ferricyanide were incubated with DEPC either in theabsence of ascorbate (sample “D” in Fig. 2) or in the presence of
ascorbate (sample “D+A”) and compared with unmodiﬁed samples
(sample “C”, control). After incubation, DEPC was removed from the
sample and the haem reducibility of the modiﬁed samples was calcu-
lated by reduced-minus-oxidised spectra. Control Acytb561 proteins
were reducible by ascorbate and dithionite (Table 3 and Supplemen-
tary Fig. S7) and the haem content values calculated after addition of
ascorbate or dithionite were respectively taken as 100% of the reduc-
tion achievable (Table 3). When the A-paralog was modiﬁed with
DEPC, only 8% of the ascorbate-dependent reduction was achieved
compared to the ascorbate-reduced control. Using dithionite, less
than 73% of the haem reduction was obtained compared to the sodi-
um dithionite-reduced EcAcytb561-AH control (Table 3). When incuba-
tion with DEPC was performed in the presence of ascorbate, the
ascorbate dependent reduction was partially inhibited (42%) and the
dithionite reduction was almost identical to the control (Table 3). A
very similar scenariowas observed for the B-paralog.When the B-paralog
was modiﬁed with DEPC, only 36% of the ascorbate reduction compared
to the control was achieved (Table 3). In contrast to the A-paralog, the
DEPC modiﬁed B-paralog could be fully reduced by dithionite (112%).
After incubation with DEPC in the presence of ascorbate, the ascorbate-
dependent reduction was only partially inhibited (54%). Using dithionite,
the B-paralogwas reduced to an identical degree compared to the control
(95%).
Fig. 4. Dependence on pH of ascorbate reducibility and of haem content for the recombi-
nant A. thaliana cyt b561 paralogs. The puriﬁed cytochromes were separated by IEF. Haem
groups reduction by ascorbate and dithionite of the fractions at different pH values were
determined via spectroscopy. (a) Ascorbate reducibility (open circles) and dithionite
reducibility (full circles) of EcAcytb561-AH. (b) Ascorbate reducibility (open squares) and
dithionite reducibility (full squares) of PpAcytb561-BSH. (c) The amount of dithionite-
reducible haemof EcAcytb561-AH (open circles) and PpAcytb561-BSH (full squares)was rede-
terminated after 2 days at room temperature and is shown as the percentage of the initial
one (dithionite reduction of EcAcytb561-AH and PpAcytb561-BSH in panels a and b).
Table 3
Overview of the speciﬁc midpoint potentials, dithionite and ascorbate haem reducibility of
Reference Enzyme Substrate/
inhibitor
EM,bL [
Desmet et al., 2007 [20] S.c. Tcyt b561 – 20
(+/−1
This work Cyt b561- A – 36
(+/−4
This work Cyt b561- A + DEPC −193
(+/−5
This work Cyt b561- A + DEPC 71
+ ASC (+/−6
This work Cyt b561- B – −22
(+/−6
This work Cyt b561- B + DEPC −233
(+/−6
This work Cytb561- B + DEPC −43
+ ASC (+/−3
a The standard deviations are shown in parentheses.
b r = correlation coefﬁcient.
c asc = with ascorbate.
d di = with sodium dithionite.
e The haem reducibility by ascorbate of the not-treated sample is set to 100%. The values
f The haem reducibility by dithionite of the not-treated sample is set to 100%. The values
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ently treated samples: The speciﬁc activities of the controls were set
to be 100%. In comparison to the control (unmodiﬁed samples) the
DEPC-modiﬁed A-paralog displayed a relative catalytic activity
(RCA) of 11% and the DEPC-plus-ascorbate modiﬁed A-paralog of
only 10%. For the B-paralog we monitored roughly the same effects:
The DEPC-modiﬁed sample exhibited a RCA of 13% and the DEPC-
plus-ascobate modiﬁed sample of only 3% (Fig. 2c and d). Ascorbate
reduction of the Acytb561 proteins modiﬁed by DEPC in the absence
(i) or presence (ii) of ascorbate was slower than that of the unmodi-
ﬁed samples. These results matched the observations for cyt b561 from
bovine chromafﬁn vesicles: It was reported that treatment with DEPC
plus ascorbate led to a slower reduction of the high potential haem of
the cyt b561 from bovine chromafﬁn vesicles [46–49].
To determinewhether DEPCmodiﬁed the haemmidpoint potential,
redox titrationswere performed. The EM7.2 values of the DEPC-modiﬁed
Acytb561 proteins were analysed according to the same procedure used
to analyse the unmodiﬁed ones. The redox titration curves conﬁrmed
the presence of two titratable haem centres (Supplementary Fig. S8).
The values of the haem redox midpoint potential of the DEPC-
modiﬁed-paralog were found to be−193 mV and 140 mV (before in-
cubation with DEPC they were 36 mV and 187 mV), while the EM7.2
values of B-paralog were found to be−233 mV and−101 mV (before
incubation with DEPC they were−22mV and 85 mV; Table 3 and Sup-
plementary Fig. S8). The values of the haem redoxmidpoint potential of
the DEPC-modiﬁed A. thaliana cyt b561 paralogs trigger new questions
on the differences residing in both haem centres of the two paralogs.
We thus performed new redox titrations with enzymes modiﬁed with
DEPC and ascorbate. We found the haem redox midpoint potential
values of the A-paralogmodiﬁedwith DEPC in the presence of ascorbate
to be 71 mVand 220 mV, respectively. The values for the B-paralog after
the same treatment were found to be −43 mV and 78 mV. These are
displayed graphically for a better comparison in Fig. 2a and b.
4. Discussion
4.1. Production of Acytb561 paralogs for biochemical studies
Investigations of both cytochromes are of particular interest as no
three-dimensional structure of any CYBASC member has beenthe recombinant Acytochrome b561 enzymes.
mV]a EM,bH [mV]a rb Haem reducibility
ascc did
178
4) (+/−15)
187 0.9917 100%e 100%f
) (+/−2)
140 0.9614 8%e 73%f
) (+/−4)
220 0.9654 42%e 108%f
) (+/−8.0)
85 0.9940 100%e 100%f
) (+/−3)
−101 0.9958 36%e 112%f
) (+/−3)
78 0.9828 54%e 95%f
) (+/−2)
of the treated samples are relative to the not-treated sample.
of the treated samples are relative to the not-treated sample.
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been characterised biochemically and they are all related to the ﬁrst
identiﬁed CYBASC proteins, the bovine chromafﬁn vesicle cyt b561 or
to the cytb561-A from A. thaliana. These two members were charac-
terised by the presence of an asymmetrical α-band in their absorp-
tion spectra, so that this asymmetry was regarded as a common
feature of cyt b561 orthologs [18]. The heterologous production in
E. coli and P. pastoris of a CYBASC protein described here that did
not show this common spectroscopic feature, but conserved surpris-
ingly well the other relevant biochemical characteristics, is thus of
great importance. The symmetric α-band of Acytb561-B demonstrated
here excludes the asymmetry of the α-band as a common CYBASC
feature. Apart from the description of cyt b561 from duodenum
(Dcytb561 [9,11]), other CYBASC members, such as the lysosomal
[7,50] and erythrocyte [12] cytb561 proteins, have so far not
been characterised extensively. Therefore, the investigation of the
Acytb561 enzymes may also facilitate a deeper understanding and bio-
chemical investigations on these members. The identiﬁcation of a
CYBASC member that shows ‘atypical’ features has increased interest
in this hydrophobic electron-transporter superfamily.
4.2. The dataset of the haem redox midpoint potentials is fully consistent
with ascorbate oxidation activity and the Fe3+-chelates reductase
activity determined in this work
Due to the use of an accurate haem redox titration procedure (see
Section 2.10 and the supplementary material), we present the ﬁrst set
of data that shows complete consistency between haem redox titra-
tion, ascorbate titration, the presence of the Fe3+-chelates reductase
activity and kinetic measurements for CYBASC members. Puriﬁed
paralogs could not be reduced fully by ascorbate (up to 80% haem re-
duction even in the presence of 40 mM ascorbate, Fig. 2e) and full
haem reduction was achieved only with dithionite. Accordingly, the
midpoint redox potential values for the respective low-potential
haem groups of the puriﬁed A- and B-paralogs were both clearly
lower than 60 mV at pH 7.2. In addition, our data are in agreement
with the ferric-reductase activities (Fig. 3a–d, f), especially with the
capability of both A. thaliana cytochromes to reduce Fe3+-EDTA
(standard redox potential=+130 mV [51]). The lower speciﬁc activ-
ities for the reduction of Fe3+-citrate could be explained by its
higher redox potential (+200 mV [8]). For both Fe3+-chelates, the
A-paralog displayed a higher activity. The reduction activity of the
DEPC-treated A-paralog is approximately in the same range as the
unmodiﬁed B-paralog. Alternating energetically “uphill” and “down-
hill” electron transfer along chains of prosthetic groups is well estab-
lished to occur based on work on other electron transfer proteins,
such as photosynthetic reaction centres, hydrogenase [52] and
dihaem-containing fumarate reductase [53], as long as the “edge-to-
edge” distance between consecutive cofactors is maximally 14 Å
[52] and the overall process is energetically favourable.
Finally our results indicated that the high potential haem groups
of both paralogs are involved in Fe3+-chelates reduction. In the tono-
plast of A. thaliana, a vacuolar membrane transporter VIT [54] was
identiﬁed. This transporter, as with all iron transporters currently
known, can catalyse the transport of iron across the cell membranes
only when iron is present in the reduced state (Fe2+). However,
due to the high reactivity of the Fe2+ ion (Fenton reaction [55]),
iron is normally stored in the cells in the oxidised state (Fe3+) in
complexes with chelators. Therefore, to transport iron inside the vac-
uole, the Fe3+-chelator complex must be reduced to Fe2+ and this
function could be performed by the A-paralog, in the same manner
as for the duodenal cyt b561 [10]. Since the Acytb561-A is localised in
the membrane of the tonoplast [19], the internal pH of the vacuole
is 5.5 [56] and in Fig. 4 it is shown that at this pH the A-paralog is al-
most reducible by ascorbate, it can be speculated that if the low-
potential haem of the A-paralog faces the internal side of the vacuole,its reduction by ascorbate can still occur. However ascorbate concen-
tration into the vacuole seems to be very low and might limit the ca-
pacity of CYBASC proteins to reduce cytosolic iron chelates. In the
cytosol, ascorbate is in the millimolar range or more. NRAMP3 and
4-iron transporters are speciﬁc for the Fe2+ transport outside the
vacuole [57]. So it could be also possible that CYBASC proteins assist
vacuolar iron efﬂux, rather than inﬂux.
4.3. Inhibition of the low-potential haem by DEPC
DEPC can modify with high afﬁnity histidine residues by reacting
with a deprotonated nitrogen atom of the imidazole ring [58]. It has
been proposed that DEPC inhibition of CYBASC proteins is caused by
covalent modiﬁcation of one or more of the His residues that coordi-
nate the haem centres [46–49]. Incubation of the puriﬁed A- and
B-paralogs with DEPC resulted in the inhibition of their ascorbate-
dependent reduction (Table 3). One remarkable point was that after in-
cubation with DEPC both Arabidopsis paralogs retained their haem
groups. As the absorbance at 415 nm of the oxidised cytochromes was
not affected profoundly by incubation with DEPC, inhibition by DEPC
is not caused by the loss of any haem centre.
To investigate the reason(s) for this inhibition, haem redox titra-
tions of the DEPC-modiﬁed A- and B-paralogs were performed. The
redox titration of the DEPC-modiﬁed A-paralog showed clearly that
the midpoint potential of the low-potential haem was modiﬁed
(Supplementary Fig. S8). While the difference ΔEM,bH in the midpoint
potential values for the high potential haem between unmodiﬁed and
DEPC-modiﬁed samples was only 47 mV, the corresponding differ-
ence is approximately ﬁve times larger for the low potential haem,
ΔEM,bL being 229 mV.
We could not observe this differential effect for the B-paralog:
Here we found that both haem midpoint potentials were modiﬁed
with ΔEM,bL=211 mV and ΔEM,bH=186 mV. Comparison of the
amino acid sequences of A and B-paralog (Supplementary Fig. S1) re-
veals the presence in the B-paralog of an additional His residue in the
proximity of the haem proposed to be involved in electron donation
to the MDHA (His 46). This could explain why both midpoint poten-
tials were modiﬁed in the B-paralog and not in the A-paralog.
In contrast, after incubationwith DEPC and ascorbate, we found that
both haem centres exhibited almost unaltered midpoint potentials
compared to the unmodiﬁed samples (Table 3, Fig. 2a and b) with
ΔEM,bL=35 mV and ΔEM,bH=33mV for the A-paralog (Fig. S8c) and
ΔEM,bL=21 mV and ΔEM,bH=7 mV for the B-paralog (Fig. S8f). Based
on these results, we can deduce the ascorbate-binding site to be near
to the low-potential haem in the A-paralog. By binding to the enzyme,
ascorbate could protect the low-potential haem centre from modiﬁca-
tion by DEPC, as has been shown previously for the bovine enzyme
[3,43]. The topology model, where the haem bL centre is next to the
ascorbate binding site [23,39,40,43] is in conﬂict with the results from
Desmet et al., 2011 [20] and Liu et al., 2011 [59]. EPR measurements
[20], redox- and ascorbate titrations of the wild type and variants of
the cyt b561 proteins [20,59] were performed which indicated haem
bH to be closer to the ascorbate binding site. However, our redox titra-
tion of the different modiﬁed samples indicated the ascorbate binding
to be closer to haem bL.
Neither paralogs could be reduced fully by ascorbate (Table 3; 8%
for the A-paralog and 36% for the B-paralog) and the RCA is only 11%
(A-paralog) and 13% (B-paralog) after incubation with DEPC (in the
absence of ascorbate). These results are generally consistent with
the modiﬁed midpoint potentials. Based on the EM7.2 values the
expectation after incubation with DEPC in the presence of ascorbate
would be that the haem reducibility by ascorbate is in the same
range as in the control. However, we found also a signiﬁcant inhibi-
tion of ascorbate oxidation activity after incubation with DEPC
and ascorbate for both paralogs (42% for the A and 54% for the
B-paralog) and the RCA are only 10% (A-paralog, Fig. 2c, sample
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must be due to an additional mechanism of inhibition, unrelated to
the haem EM values [43]. In 2009, Nakanishi et al. [60,61] showed
that DEPC in Zmb561 modiﬁed not only the histidines but also
the conserved lysine 83 (corresponding to Acytb561-A K80 and
Acytb561-B K81). This lysine 83 should be involved in the electron/
proton transfer [60,61] across the membrane and/or a very impor-
tant role for the ascorbate access. While the histidine residues are
protected by the ascorbate between the incubation with DEPC plus
ascorbate, this conserved lysine is expected to be modiﬁed by
DEPC. This modiﬁcation could have a signiﬁcant effect on the acces-
sibility and/or afﬁnity of the binding site for ascorbate. This could
be a possible explanation for the diminished haem reducibility and
the low RCA in both paralogs.5. Conclusion
For the ﬁrst time, two CYBASC members (ACytb561- A and
ACytb561- B) from A. thaliana have been produced both in the E. coli
and in the P. pastoris expression systems. We demonstrated that the
reduction of the puriﬁed paralogs by the physiological electron
donor ascorbate depends on the pH. In addition we have determined
speciﬁc activities of the oxidation of ascorbate and of the reduction of
ferric chelates for both paralogs. Furthermore our results have con-
ﬁrmed an inhibition of ascorbate reduction by DEPC of both paralogs
which is partially blocked by the pre-incubation with ascorbate. The
EM7.2 values of the DEPC-modiﬁed samples differed clearly from the
control while our samples treated with DEPC and ascorbate displayed
nearly the same EM values as the control. In both paralogs, the haem
bL potentials are lowered by treatment with DEPC. The protection of
the haem bL potential by ascorbate indicated that the ascorbate bind-
ing site is next to the haem bL centre. In contrast to the EM values, the
relative catalytic activities of ascorbate oxidation of both paralogs,
modiﬁed with DEPC either in the presence or absence of ascorbate,
were reduced to only about 10% of the control. Consequently, there
must be an alternative site modiﬁed by DEPC that is not protected
by ascorbate but involved in the accessibility and/or afﬁnity of the
binding site for ascorbate. The production and the characterisation
presented here provide prerequisites for future structural and mech-
anistic analysis of members of the CYBASC protein family.Acknowledgement
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